GE
GE Aerospace
stock NYSE

The December 2025 GE extension was the strongest de-risking event this company can generate and the stock didn't move, because nothing can move it. A total of about $3K of stock trades daily, no analyst covers it, no institution can build a position, management has never returned capital, and the one uplisting attempt (the Achari SPAC) was terminated in September 2024. Operating economics are also genuinely mediocre: FY2025 showed an operating loss of $2.9M and negative adjusted EBITDA, with SG&A growing faster than gross profit.
Also worth noting that compensation is 100% cash. No options, no RSUs. Management's economics are indifferent to the 19-cent quote. The share price could halve or triple and nobody's paycheck would change. That's the compensation-design explanation for why a company with enterprise value near zero has never bought back a share.

GE exploded afterward - and GEV

Interesting setup, but I think the thesis needs a few caveats.
The cash balance looks attractive, but not all of it should be treated as excess cash because the company also carries substantial contract liabilities tied to the GE business.
The potential NetWolves sale could be the catalyst, but right now it is still speculation. The filing suggests strategic activity, not that a sale is definitely happening.
Also, Q1 was weak. The healthcare segment posted a small operating loss despite revenue growth, largely because expenses increased. So the argument that this is already a clean $6–7 million earnings business is probably too aggressive.
Personally, this looks like a business that won’t be around much longer. You’ve really got to ask why they exist at all in today’s climate. I think you’re taking on a ton of risk for relatively minimal upside.

Netwolves being sold would be great for them. Really solid DD and using the primary filings to build this was A+. Biggest question is why has GE not bought them?

MU, GE, and BX. Close fourth is GEV. BX is killing me this year.

Moderna, GE, RITM,

Thank you for the write up. From my understanding, the merger with the GE train division was a huge boost in what they are today. It gave them end to end locomotive manufacturing.
They kind of are becoming a "tech company." They are pioneering ai capability for trains. I could see that as a huge growth opportunity. They already have great recurring revenue models from repair and updates, but if they can package software, and artificial intelligence that will be another recurring revenue stream.
It is hard to judge locomotive stocks, because they perpetually trade at an expensive premium. They are cyclical, but it's hard to know when the cycle will cool off. I like wabtec because they are a little more insulated since they operate all over the world. It's not like union Pacific where if there is a slowdown, they are carrying less freight.

I believe GE had a reverse split right after the new CEO started and it performed very well after.

If those 3 stocks stumble your entire portfolio is going to crash. They have been great now but things change. 20 years ago the top 3 companies were Exxon GE and Microsoft… you’re not investing you’re gambling right now

I am surprised there are others who own Wabtec. Stock is at $262.19. Stock Symbol WAB. It was an under appreciated dog from the 1990s to 2010
Westinghouse Air & Brake
Westinghouse was a GINORMOUS company in the 1960s and 1970s. Westinghouse is the guy who funded Tesla and Alternating Current to take on Thomas Edison and his Direct Current. This made Westinghouse very rich.
You had Westinghouse and General Electric competing against each other.
A lot of my friends parents worked at Westinghouse. Then, new CEOS messed it all up in the 1980s and it marched downhill very fast.
Think train engines and railroad cars. I always laughed when they called themselves "Technology", just to use the buzzword, back in the 1990s/2000s.
Did a merger with GE Transportation not too long ago.
You want that product you imported at the docks in the US Ports in Long Island, Houston, New Jersey to get someplace, you need trains.
Personally, I think it is over-priced, but I ain't complaining.
only recently started annual dividend raises.

GE though.

## 📈 52-Week Highs:
The 52-Week Highs list shows stocks that have reached their highest price point in the past 52 weeks during the trading session.
| Symbol | Name | Price | Year High | Market Cap |
|:-------|:-----|:-----:|:---------:|:----------:|
| [V](https://marketrodeo.com/asset/V) | Visa Inc. | $362.13 | $362.13 | $694.1B |
| [JNJ](https://marketrodeo.com/asset/JNJ) | Johnson & Johnson | $263.04 | $263.06 | $633.2B |
| [ABBV](https://marketrodeo.com/asset/ABBV) | AbbVie Inc. | $261.07 | $261.63 | $461.3B |
| [GE](https://marketrodeo.com/asset/GE) | GE Aerospace | $377.52 | $382.97 | $394.4B |
| [UNH](https://marketrodeo.com/asset/UNH) | UnitedHealth Group Incorporated | $425.36 | $430.20 | $386.3B |
## 📉 52-Week Lows:
The 52-Week Lows list shows stocks that have reached their lowest price point in the past 52 weeks during the trading session.
| Symbol | Name | Price | Year Low | Market Cap |
|:-------|:-----|:-----:|:--------:|:----------:|
| [T](https://marketrodeo.com/asset/T) | AT&T Inc. | $20.57 | $19.89 | $142.9B |
| [FITBO](https://marketrodeo.com/asset/FITBO) | Fifth Third Bancorp | $17.90 | $17.90 | $47.7B |
| [FITBP](https://marketrodeo.com/asset/FITBP) | Fifth Third Bancorp | $23.12 | $23.05 | $46.9B |
| [RVMDW](https://marketrodeo.com/asset/RVMDW) | Revolution Medicines, Inc. Warrant | $9.55 | $0.39 | $40.5B |
| [MPLXP](https://marketrodeo.com/asset/MPLXP) | MPLX Lp | $33.38 | $33.38 | $33.4B |
**Source:** [52-Week Highs-Lows](https://marketrodeo.com/market-movers?tab=highs-lows)

GE vernova earnings and ROIC are superior to Siemens

GE the most famous example you can not only survive but soar assuming you do something drastic like break up the compqny

I would go for a combination of stocks based on region
Regions being (my division is based on area, follow your own based on research)
USA- 70000 (please go for a balanced approach, to shield from tech drawdowns)
Stocks I would go for: NVIDIA, Apple, alphabet, Amazon, Lam research, Robinhood, Moderna, GE Vernova, Nebius, General Dynamics corporation
Emerging markets- 50000 (my fav here are China, Taiwan, Korea, LATAM)
Stocks to look for (although I would personally recommend going via funds): BYD, MPI corporation, Chroma ate, SK Hynix, Samsung, TSMC, Tencent
Europe- 30000 (include UK as well, despite Brexit)
Stocks to check out: ASML, Roche, Medtronic, Rolls Royce, Ferrari, Visa, Alcon AG

The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.
## 📉 **Oversold Stocks:**
Stocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.
| Symbol | Company | RSI | Price | Change | %Change | Market Cap |
|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|
| [WMT](https://marketrodeo.com/asset/WMT) | Walmart Inc. | 25.11 | 111.84 | +3.02 | +2.78% | $890.0B |
| [ORCL](https://marketrodeo.com/asset/ORCL) | Oracle Corporation | 28.79 | 140.27 | -2.23 | -1.56% | $404.0B |
| [KLAC](https://marketrodeo.com/asset/KLAC) | KLA Corporation | 26.33 | 235.55 | -30.64 | -11.51% | $307.7B |
| [BABA](https://marketrodeo.com/asset/BABA) | Alibaba Group Holding Limited | 23.12 | 96.14 | -1.85 | -1.89% | $230.8B |
| [TTE](https://marketrodeo.com/asset/TTE) | TotalEnergies SE | 26.06 | 76.69 | +1.89 | +2.53% | $170.8B |
Source: [Oversold](https://marketrodeo.com/screener?rsiLowerThan=30&exchange=NASDAQ%2CNYSE%2CAMEX)
## 📈 **Overbought Stocks:**
Stocks with RSI above 70, potentially indicating overbought conditions and possible downward reversals.
| Symbol | Company | RSI | Price | Change | %Change | Market Cap |
|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|
| [SPCX](https://marketrodeo.com/asset/SPCX) | Space Exploration Technologies Corp. | 74.55 | 161.81 | +4.27 | +2.71% | $2.1T |
| [V](https://marketrodeo.com/asset/V) | Visa Inc. | 70.96 | 362.13 | +11.05 | +3.15% | $694.1B |
| [ABBV](https://marketrodeo.com/asset/ABBV) | AbbVie Inc. | 72.28 | 261.07 | +10.01 | +3.99% | $461.3B |
| [GE](https://marketrodeo.com/asset/GE) | GE Aerospace | 75.38 | 377.52 | +2.58 | +0.69% | $394.4B |
| [RY](https://marketrodeo.com/asset/RY) | Royal Bank of Canada | 80.93 | 204.79 | -3.52 | -1.69% | $284.6B |
Source: [Overbought](https://marketrodeo.com/screener?rsiMoreThan=70&exchange=NASDAQ%2CNYSE%2CAMEX)
**Understanding RSI:**
- **RSI < 30:** Potentially oversold (stock may be undervalued)
- **RSI > 70:** Potentially overbought (stock may be overvalued)
- **RSI 30-70:** Normal trading range

eqtmonline on youtube
This move reshapes India's nuclear value chain from construction and fuel systems to power generation. Here are the three listed companies directly positioned within the shift.
Number one, Larsen & Toubro. L&T is a key EPC player in India's nuclear power sector. It builds critical infrastructure for pressurized heavy water reactors, lightwater reactors and natural draft cooling towers. In September 2025, L&T won a Rs 25 billion order from NPCIL for Kundam Kulam nuclear power project unit 5 and 6. The scope includes reactor installation, turbine systems and seawater systems. Over the last 5 years, L&T's revenue grew at 12% while net profit grew at 11.7%.
Second, NTPC. NTPC has entered nuclear power through joint ventures with NPCIL. In September 2025, the foundation stone was laid 2,800 megawatt Mahi Bansswara nuclear power project where NTPC holds a 49% stake. The project uses four indigenous 700 megawatt PHWRS. Over 5 years, NTPC's revenue grew at 11.5% and net profit growing at 15%.
Third, GE Vernova T&D India through its GE Vernova Hitachi Nuclear Energy Alliance is a global leader in advanced nuclear reactors. Fuel and nuclear services capabilities span the entire nuclear plant life cycle including refueling outages, non-destructive examinations and MW capacity updates. Over 5 years, revenue grew at 6.3% while net profit rose from Rs 603 million to Rs 6,083 million.
The Shanti bill removes long-standing barriers in India's nuclear sector, but policy change alone is not enough. Understanding fundamentals and execution capability remains essential.